Pneumomediastinum medical therapy

Revision as of 18:45, 14 December 2018 by Trushatank (talk | contribs)
Jump to navigation Jump to search

Pneumomediastinum Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Pneumomediastinum from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Case Studies

Case #1

Pneumomediastinum medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Pneumomediastinum medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pneumomediastinum medical therapy

CDC on Pneumomediastinum medical therapy

Pneumomediastinum medical therapy in the news

Blogs on Pneumomediastinum medical therapy

Directions to Hospitals Treating Pneumomediastinum

Risk calculators and risk factors for Pneumomediastinum medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Trusha Tank, M.D.[2]

Overview

Pneumomediastinum is considered a benign condition. The first step in the treatment is the exclusion of any significant pathology causing pneumomediastinum and if diagnosed, treat the underlying conditions. In case of spontaneous pneumomediastinum without any complications, patients are required to be hospitalized for 24 hours for observational purposes.

Medical therapy

  • Pneumomediastinum is considered a benign condition[1][2].
  • The first step in the treatment is the exclusion of any significant pathology causing pneumomediastinum and if diagnosed, treat the underlying conditions such as exacerbation of asthma, COPD, pneumonia, pneumothorax, Boerhaave syndrome, mediastinitis, bronchiectasis or ARDS.
  • In case of spontaneous pneumomediastinum without any complications, patients are required to be hospitalized for 24 hours for observational purposes.

Other treatment options are the following:

References

  1. Agut A, Talavera J, Buendia A, Anson A, Santarelli G, Gomez S (2015). "IMAGING DIAGNOSIS-SPONTANEOUS PNEUMOMEDIASTINUM SECONDARY TO PRIMARY PULMONARY PATHOLOGY IN A DALMATIAN DOG". Vet Radiol Ultrasound. 56 (5): E54–7. doi:10.1111/vru.12223. PMID 25388364.
  2. Koullias GJ, Korkolis DP, Wang XJ, Hammond GL (May 2004). "Current assessment and management of spontaneous pneumomediastinum: experience in 24 adult patients". Eur J Cardiothorac Surg. 25 (5): 852–5. doi:10.1016/j.ejcts.2004.01.042. PMID 15082293.

Template:WH Template:WS